Bee products for heart health in coronary artery disease
Part of Heart & circulation clinical trials.
This trial tests whether taking royal jelly and propolis (natural bee products) can improve heart health and reduce inflammation in people with coronary artery disease. It may help lower cardiovascular risk and improve how your body processes fats and sugars.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have coronary artery disease (blocked or narrowed heart arteries) confirmed by a doctor's test.
- Your heart condition is stable — no recent heart attack or unstable angina in the last year.
- You are not waiting for heart surgery or a procedure to open blocked arteries.
- You do not have advanced kidney disease (with very low kidney function) or an autoimmune disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two bee products—propolis and royal jelly—can help reduce inflammation and stress in the body of people with high blood pressure. Researchers want to see if adding these supplements to your current blood pressure medication helps control the condition better.
This study tests whether taking ginger can help reduce inflammation and oxidative stress (cell damage) in people with coronary artery disease. It may help improve heart health by lowering harmful chemicals in the blood.
This study tests if taking royal jelly, a natural substance made by bees, can reduce inflammation and stress in the body for people with high blood pressure (stage 1). It may help control blood pressure better.
This study tests whether red propolis, a natural bee product, might help slow kidney disease progression in people with moderate to advanced chronic kidney disease who aren't yet on dialysis. Researchers believe its anti-inflammatory properties could support kidney health.
This study looks at whether a comprehensive add-on treatment—starting with immune medicine and then a heart procedure when needed—can improve outcomes for people whose coronary artery disease is getting worse quickly. It focuses on cases where inflammation is likely driving new artery blockages or worsening chest pain.
This trial tests a special balloon coated with medicine to treat blocked small arteries in the heart. It may help people who have new blockages and are getting a procedure to open those arteries.
Hear when a new Oxidative Stress trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.